RecruitingPhase 2NCT05937854
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Studying Pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- VA Office of Research and Development
- Principal Investigator
- Sharon I Rounds, MDProvidence VA Medical Center, Providence, RI
- Intervention
- Tadalafil(drug)
- Enrollment
- 126 enrolled
- Eligibility
- 35-89 years · All sexes
- Timeline
- 2024 – 2029
Study locations (5)
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha, Nebraska, United States
- Providence VA Medical Center, Providence, RI, Providence, Rhode Island, United States
Collaborators
VA Boston Healthcare System · Atlanta VA Medical Center · VA Eastern Colorado Health Care System · VA Nebraska Western Iowa Health Care System
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05937854 on ClinicalTrials.govOther trials for Pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07593027A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
- RECRUITINGNANCT07563322Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary HypertensionVanderbilt University Medical Center
- ACTIVE NOT RECRUITINGNANCT07391228Cognitive Alterations in Pulmonary Arterial Hypertension (PAH)Alessandra Gorini
- RECRUITINGNANCT06871293Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19Fundación Cardioinfantil Instituto de Cardiología
- RECRUITINGNANCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionTempus AI
- ACTIVE NOT RECRUITINGPHASE3NCT06274801Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)GB002, Inc.
- RECRUITINGNCT06291389Intraoperative Peak Airway Pressure Changes on Postoperative Pulmonary Function After Muscle PlicationAl-Azhar University
- ACTIVE NOT RECRUITINGNANCT07253363Circulating Activin-A and FSTL3 in Precapillary Pulmonary HypertensionAssistance Publique - Hôpitaux de Paris